Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
COVID-19
Unintended Consequences of COVID-19 on Oncology
Don McDaniel, MBA
,
Michael Consuelos, MD, MBA, FAAP
Read More
Online Only
COVID-19
Oncology Nursing and Cancer Care
Read More
Online Only
COVID-19
Patient Advocacy During the Pandemic
Read More
CMS Expands Access to Telehealth Benefits During COVID-19 Outbreak
Read More
Ovarian Cancer
,
PARP Inhibitors
Key Clinical and Operational Considerations in Practice-Based Dispensing of PARP Inhibitors and Other Oral Oncology Agents
Read More
Ovarian Cancer
ASCO Updates Its Oncology Medical Home Payment Model
Read More
Ovarian Cancer
Pooled Analysis Finds No Definitive Link Between Talc-Based Powders and Ovarian Cancer
Read More
Supportive Care
Steroids plus Exercise Reduce Fatigue in Patients with Advanced Cancer
Corbin Davis
Read More
Meeting Highlights
ESMO Highlights
Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations
Phoebe Starr
Read More
Original Research
,
Infusion Issues
,
Infusion Issues
,
Pediatric Cancer
,
Pediatric Cancer
Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or Intramuscular Asparaginase Agents
Zachery Halford, PharmD, BCOP, BCPPS
,
Megan Park, PharmD, MBA, DPLA
Zachery Halford, PharmD, BCOP, BCPPS; Megan Park, PharmD, MBA, DPLA
Read More
135
136
137
138
139
140
141
Page 138 of 196
Results 1371 - 1380 of 1954